Standardizing Human Review Requirements for AI Across Clinical and Back-Office Workflows

What to standardize and what to let vary

Most healthcare organizations set human review rules team by team. Clinical documentation, decision support, and patient communication follow one set of habits. Claims, prior authorization, coding, and scheduling follow another. The rules usually exist in policy documents, but the systems where AI acts do not enforce them, and each team produces different records. The result is unclear criteria for when a person must approve an AI action and no consistent way to show an auditor what review was required.

The fix is to separate the parts of the standard that should be identical everywhere from the parts that should differ. Four elements belong in the common standard: the risk tiers, the trigger conditions that require review, the accountability of the reviewer, and the evidence requirements. Two inputs legitimately vary by workflow: the consequence of the AI action, which differs between clinical and administrative settings, and the degree of PHI exposure.

This split keeps the standard small enough to enforce. A claims team and a clinical documentation team should not need different definitions of what counts as an approval. They should need different answers to the question of which tier their workflow belongs in.

Step 2: Set review triggers and assign reviewer roles

A tier tells you how much review to expect. A trigger tells you when a specific action needs a person. Three review models cover most cases: pre-action approval, sampled review after the fact, and exception-based escalation. Pre-action approval fits Tier 1. ONC's SAFER guidance supports this baseline for patient-facing output: AI-generated recommendations should be reviewed and approved by humans who take responsibility for them before they are sent to patients. Exception-based escalation fits Tier 2, where most actions proceed but defined conditions pull in a reviewer.

Write triggers as conditions a system can evaluate, not as intentions. Examples include the action type (sending a message to a patient, writing to a record, issuing a denial), the presence of PHI in the request or tool arguments, and the destination of the output. A trigger that cannot be evaluated by software will remain a policy statement.

Reviewer roles need named accountability. Define who may approve each tier, for example a licensed clinician for clinical output and a qualified staff member for administrative output. Also consider what the reviewer sees. FDA's clinical decision support guidance ties independent clinician review to the ability to understand the basis for a recommendation. An approval step is only meaningful if the reviewer can see that basis in a usable form.

Back-office queues carry timing constraints. As of November 2026, CMS requires impacted payers to send prior authorization decisions within 72 hours for expedited requests and 7 calendar days for standard requests. CMS materials also list clinician review of clinical denials and describe a model that pairs AI/ML with clinician review. Counsel should confirm how that applies to your organization. Reviewer staffing and escalation routing should be sized against those timeframes.

Governance decisions and rollout

SAFER describes shared responsibility among AI developers, EHR vendors, and healthcare organizations. Document which party enforces review and which party retains the evidence, especially where AI is embedded in a vendor product. Tell patients when AI is used and what role clinicians play in reviewing its output.

Start with the workflows where output reaches patients or contributes to coverage decisions, then extend the standard downward. Expect tradeoffs. Broad pre-action approval adds latency and reviewer load, while thin review weakens oversight. Tiering exists to place that cost where consequence is highest.

• Inventory and classify: List AI use in clinical and back-office workflows and assign each a tier.
• Write triggers as evaluable conditions: Express each trigger so that software can test it on every interaction and tool call.
• Name reviewers and queues: Assign accountable roles and size queues against decision timeframes.
• Test the evidence: Pick one interaction and confirm you can show the policy, trigger, reviewer, and decision.